Christopher A Hunter Selected Research

Toxoplasmosis

12/2004	Development of a system to study CD4+-T-cell responses to transgenic ovalbumin-expressing Toxoplasma gondii during toxoplasmosis.
08/2004	IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12.
03/2004	The NF-kappaB signaling pathway: immune evasion and immunoregulation during toxoplasmosis.

6	Inflammation 03/2007 - 10/2002
3	Toxoplasmosis 12/2004 - 03/2004
3	Infection 04/2004 - 10/2002
1	Schizophrenia (Dementia Praecox) 05/2007
1	Encephalitis (Encephalitis, Rasmussen) 08/2005
1	Atherosclerosis (Atheroma) 09/2002
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2002

3	Interleukin-17 (Interleukin 27)IBA 03/2007 - 04/2006
2	Interleukin-23 (Interleukin 23)IBA 01/2007 - 08/2004
2	Interleukin-12 (IL 12)IBA 08/2004 - 09/2002
2	NF-kappa B (NF-kB)IBA 03/2004 - 10/2002
1	Kynurenic Acid (Kynurenate)IBA 05/2007
1	InterleukinsIBA 09/2006
1	Interleukin-10 (Interleukin 10)IBA 08/2005
1	OvalbuminIBA 12/2004
1	Interleukin-4 (Interleukin 4)IBA 04/2004
1	Interferon-gamma (Interferon, gamma)IBA 11/2003
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 09/2002